Altre lingue CTCBIO Inc.

Azioni

A060590

KR7060590007

Prezzo di chiusura Korea S.E. Altri mercati azionari 00:00:00 21/05/2024			Variaz. 5gg	Var. 1 gen.
8.050 ^KRW	-6,61%		-2,42%	-24,77%

24/04	Le importazioni coreane di zucchero crollano del 14% per l'aumento dei casi di diabete	MT
21/03	CTCBIO Inc. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Korean Sugar Imports Plunge 14% as Diabetes Cases Surge	24/04
CTCBIO Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
An unknown buyer agreed to acquire an unknown minority stake in CTCBIO Inc. for KRW 20 billion.	16/08/23
CTCBIO Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23
An unknown buyer agreed to acquire 12.57229% stake in CTCBIO Inc. for KRW30 billion.	31/03/23
CTCBIO Inc. announced that it has received KRW 9.999985977 billion in funding from Bridge Co., Ltd., Hwail Pharmaceutical Co.,Ltd.	01/04/21
CTCBIO Inc. announced that it expects to receive KRW 9.999985977 billion in funding from Bridge Co., Ltd., Hwail Pharmaceutical Co.,Ltd.	22/03/21
CTCBIO Inc. announced that it has received KRW 10 billion in funding from Kiwoom Securities Co., Ltd., Samsung Securities Co.,Ltd., Mirae Asset Daewoo Co., Ltd., Shinhan Financial Investment Co., Ltd	25/09/20
CTCBIO Inc. announced that it expects to receive KRW 10 billion in funding from Kiwoom Securities Co., Ltd., Samsung Securities Co.,Ltd., Mirae Asset Daewoo Co., Ltd., Shinhan Financial Investment Co., Ltd	23/09/20
CTCBIO Inc. announced that it has received KRW 21 billion in funding from NH Investment & Securities Co., Ltd., Kiwoom Securities Co., Ltd., Samsung Securities Co.,Ltd., KB Securities Co.,Ltd, Mirae Asset Daewoo Co., Ltd., Shinhan Investment Corp.	04/10/18
CTCBIO Inc. announced that it expects to receive KRW 21 billion in funding from NH Investment & Securities Co., Ltd., Kiwoom Securities Co., Ltd., Samsung Securities Co.,Ltd., KB Securities Co.,Ltd, Mirae Asset Daewoo Co., Ltd., Shinhan Investment Corp. other investors	02/10/18
CTCBIO Inc. announced that it has received KRW 20 billion in funding from Korea Investment Partners Co. Ltd.	25/08/17
CTCBIO Inc. announced that it expects to receive KRW 20 billion in funding from Korea Investment Partners Co. Ltd. and other investors	22/08/17
CTCBIO., Inc.'s Equity Buyback announced on August 8, 2014 has expired.	04/08/15
CTCBIO., Inc.(KOSDAQ:A060590) added to Russell Global Index	29/06/15
Ferring Pharmaceuticals Acquires Novel Drug Delivery Technology from CTCBIO Inc	23/02/15
CTCBIO., Inc.'s Equity Buyback Plan Extended till August 4, 2015.	05/02/15
CTCBIO., Inc. cancelled the acquisition of a Factory in Ansan City from SK Chemicals Ltd.	17/12/14
Tranche Update on CTCBIO., Inc.'s Equity Buyback Plan announced on August 8, 2014.	11/11/14
CTCBIO., Inc. acquired drug manufacturing division of SK Chemicals Co.,Ltd.	29/09/14

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue CTCBIO Inc.

Azioni

A060590

KR7060590007

Altre lingue

Filtri